Lumiliximab
Modify Date: 2024-04-02 18:36:39
Lumiliximab structure
|
Common Name | Lumiliximab | ||
|---|---|---|---|---|
| CAS Number | 357613-86-6 | Molecular Weight | 47.75 (kDa) | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of LumiliximabLumiliximab (Anti-CD23 Recombinant Antibody) is an anti-CD23 monoclonal antibody that inhibits allergen-induced responses[1]. |
| Name | Lumiliximab |
|---|
| Description | Lumiliximab (Anti-CD23 Recombinant Antibody) is an anti-CD23 monoclonal antibody that inhibits allergen-induced responses[1]. |
|---|---|
| Related Catalog | |
| Target |
CD23[1] |
| References |
| Molecular Weight | 47.75 (kDa) |
|---|